Home » Featured » Page 33
Featured
America's foreign adversaries, chief among them China, could utilize one of the federal government's most noteworthy immigration programs against the United States, threatening its national security and undermining democracy, U.S. Rep. Guy Reschenthaler (R-PA) told Homeland Preparedness... Read More »
A new report from the Nuclear Threat Initiative (NTI) says some gaps need to be addressed in the international system to prevent and respond to biological events.
NTI is calling on national and global leaders to take action now to prevent future biological events that could match or exceed the... Read More »
Sen. Dianne Feinstein (D-CA) and Rep. Josh Harder (D-CA) are among a group of lawmakers urging congressional leadership to include a six-month extension for states and local governments to spend their funding allocations provided by the Coronavirus Aid, Relief, and Economic Security (CARES) Act in... Read More »
In the aftermath of wildfires that devastated wide swaths of land and communities, senators wrote to President Donald Trump last week requesting additional federal aid for wildfire response efforts and to assist recovery.
The senators requested quick increases to the number of fire personnel and... Read More »
A bill was introduced in the U.S. Senate that seeks to repeal or modify regulations that have impeded the ability of the government to rapidly respond to the COVID-19 pandemic.
The Pandemic Preparedness, Response, and Recovery Act establishes a commission charged with prioritizing regulation... Read More »
The ongoing COVID-19 pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats, requiring that decision makers consider improved policies, programs, and technologies to ramp up the federal defense, experts said during the Sept. 24 virtual... Read More »
A new, phase three clinical trial for Janssen Pharmaceutical Companies’ investigational COVID-19 vaccine began recruiting adult volunteers this week to see if a single dose could prevent symptomatic cases.
The trial will enroll up to 60,000 volunteers at nearly 215 clinical research sites in... Read More »
Top Trump Administration officials dismissed concerns that approval of a COVID-19 vaccine is being rushed to satisfy the President’s reelection efforts and assured the public they would volunteer to take any vaccine themselves that is ultimately approved by the government.
“We do feel the... Read More »
The Government Accountability Office (GAO) is recommending that the Treasury Department work with other federal agencies and sector partners to enhance cybersecurity within the financial sector.
The financial services sector's reliance on information technology makes it a leading target for... Read More »
The global initiative known as the COVAX facility announced major news for all seeking relief from the COVID-19 pandemic: a total of 156 economies have banded together under the program, guaranteeing both robust and lower income economies will get vaccines.
This week marked the formal commitment... Read More »
In a letter written to the Department of Justice (DOJ) and Federal Bureau of Investigation (FBI) this week, U.S. Sens. Dianne Feinstein (D-CA), Maggie Hassan (D-NH), and John Cornyn (R-TX) pressed for details on drug trafficking crackdown efforts targeting the dark web and its users.
Pointing to... Read More »
Eli Lilly and Company announced a new collaboration with Amgen last week that will allow a significant increase in supply capacity and scaling of production of its potential COVID-19 therapies.
The news came a mere day after Lilly announced that proof of concept data from its BLAZE-1 clinical... Read More »
In a letter to the U.S. Food and Drug Administration (FDA) this week, 15 Democratic senators called for the agency to be fully transparent in its COVID-19 vaccine review process, over concerns President Donald Trump is pressuring it to approve a vaccine before Election Day.
Public trust must be... Read More »
Leaders of the House Energy and Commerce Committee are seeking information from the nine pharmaceutical companies developing COVID-19 vaccines about their research and development efforts and how they are ensuring that only a safe and effective product will be made publicly available.
The... Read More »
America’s top public health officials earlier Wednesday briefed U.S. Senate subcommittee members on two documents outlining the Trump administration’s strategy to distribute over the next several months safe, effective and free COVID-19 vaccines to Americans as quickly as possible once the Food... Read More »
House Republican leaders are seeking information from the Centers for Disease Control and Prevention (CDC) on how it plans to manage COVID-19 response efforts in addition to the flu and other respiratory issues this season.
“We share your concerns about the unprecedented convergence of two... Read More »
U.S. Rep. John Katko (R-NY) introduced a build that would help equip the general public, as well as businesses and governments, with the tools and guidance to protect against cyberthreats.
The bill – the Cyber Essentials Act -- directs the Cybersecurity and Infrastructure Security Agency... Read More »
The Department of Justice’s Office of Community Oriented Policing Services (COPS) will award $50 million in funding for school safety initiatives through its School Violence Prevention Program (SVPP).
The program provides up to 75 percent funding for school safety measures for primary and... Read More »
A new report says investment in data and artificial intelligence (AI) is needed to drive the health system improvements needed to respond to and recover from the COVID-19 pandemic.
The study – called Reimagining Global Health through Artificial Intelligence: The Roadmap to AI Maturity -- was... Read More »
Amid fears of political pressures to rush a vaccine for COVID-19, nine CEOs of biopharmaceutical companies working on these candidates have signed a pledge to uphold the scientific process and safety in any development.
The companies include AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson &... Read More »
A new facility -- the National Bio and Agro-Defense Facility -- meant to house top-of-the-line labs for research into foreign animal diseases will soon transfer from the United States Department of Homeland Security (DHS) to the U.S. Department of Agriculture (USDA), but outstanding issues could... Read More »
The U.S. Department of Homeland Security (DHS) released a new report on its efforts to combat Electromagnetic Pulse (EMP) attacks, which could disrupt the electrical grid and potentially damage electronics.
The report, called the Electromagnetic Pulse (EMP) Program Status Report, establishes... Read More »
The intravenously administered drug Kevzara will no longer be investigated as a potential COVID-19 treatment, Sanofi confirmed this week, after it failed to meet either its primary or secondary goals during a phase 3 trial among severely and critically ill patients.
Hundreds were tested with the... Read More »
A contract between Royal Philips and the U.S. Department of Health and Human Services (HHS) that would have brought 43,000 bundled EV300 ventilator configurations to the Strategic National Stockpile will be terminated after fulfillment of just 12,300 this month.
“To date, we have delivered on... Read More »
The United Kingdom-based biopharmaceutical company AstraZeneca launched phase 3 testing of its potential COVID-19 vaccine -- AZD1222 -- in the United States this week, with plans to enroll as many as 30,000 adult volunteers across 80 testing sites.
AZD1222 was originally developed by Oxford... Read More »
The U.S. Food and Drug Administration (FDA) last week expanded the emergency use authorization (EUA) for the drug Veklury (remdesivir) to allow its use on all hospitalized patients with suspected or lab-confirmed cases of COVID-19.
Its use was formerly restricted by severity, but those... Read More »
Seeking greater investigations into how and where viruses and other pathogens can crossover from wildlife to people, the National Institute of Allergy and Infectious Diseases (NIAID) officially created the Centers for Research in Emerging Infectious Diseases (CREID) this week through an initial 11... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) is searching for new ways to deliver vaccines, and to do so, it has found four partners in research: Esperovax, Inc., the University of Connecticut, Vaxess Technologie, and Verndari, Inc.
The two options being investigated... Read More »
Changes to the requirements for emergency use authorization (EUA) of convalescent plasma as a COVID-19 treatment by the U.S. Food and Drug Administration (FDA) has raised new barriers for hospitals, and a new line of questions from U.S. Reps. Debbie Dingell (D-MI) and Fred Upton (R-MI).
In a... Read More »
Thanks to the efforts of nearly 40 companies and universities in the state of Maryland, millions of dollars have been dedicated to the research and development of vaccines, therapeutics, and tests for COVID-19, Gov. Larry Hogan announced this week.
Those efforts include millions in funding... Read More »
Despite its far-reaching effects, there remains no standardized reporting of COVID-19-related data within the United States, a fact that prompted the introduction of the Health STATISTICS Act of 2020 to the House last week.
The legislation was introduced by U.S. Reps. Brian Fitzpatrick (R-PA),... Read More »
The U.S. Department of Health and Human Services (HHS) announced last week the cancellation of Food and Drug Administration (FDA) requirements on premarket reviews for lab-developed tests linked to COVID-19.
Pitching the change as one targeting unnecessary policies and increasing flexibility in... Read More »
In a new report on commercial drones, the conservative think tank The Heritage Foundation has laid out the expansive penetration of Chinese-manufactured drones into the U.S. market, and has argued for direct government intervention to halt their data collection activities.
Labeling these drones... Read More »
U.S. Sens. Rob Portman (R-OH) and Gary Peters (D-MI) introduced a bill designed to promote the production of personal protective equipment (PPE) in the United States.
Specifically, the Make PPE in America Act would require the Defense Logistics Agency (DLA) to issue long-term contracts for... Read More »
A bill was introduced in the U.S. House of Representatives that seeks to reverse the decrease in vaccination rates, which have plummeted during the COVID-19 pandemic.
The Community Immunity During COVID-19 Act (H.R. 8061) would make investments to evaluate and develop local initiatives to... Read More »
